glp-1 prescriptions q1 2025 The future of GLP-1s: Cost, access and more trends HR must know GLP-1 insurance coverage worsened at

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity

GLP-1 receptor agonists have emerged as a transformative tool in weight management, with clinical trials showing average weight loss of 1522% over 68 weeks in people taking these medications alongside lifestyle changes

For the right patient, microdosing a compounded GLP-1 medication (tirzepatide + methylated B12) can be a gentle, effective way to calm your body, improve digestion, and stabilize energy all while supporting hormones, metabolism, and the nervous system

"Companies have to study this

The deadline for stopping production and distribution of compounded tirzepatide passed in March